Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jan, 9 2026
Jan, 16 2026
Oct, 9 2025
Oct, 19 2025
Feb, 17 2026